Description

DUPHALAC SYRUP 150ML

Indications

DUPHALAC Syrup is primarily indicated for the treatment of constipation. It is also used to facilitate the evacuation of the bowel in patients with hepatic encephalopathy, a condition associated with liver dysfunction that can lead to confusion, altered consciousness, and other neurological symptoms. The syrup can be beneficial in softening stools, making them easier to pass, and is often recommended for patients who require a gentle laxative effect.

Mechanism of Action

DUPHALAC contains lactulose, a synthetic disaccharide that is not absorbed in the gastrointestinal tract. Upon reaching the colon, lactulose is metabolized by colonic bacteria into short-chain fatty acids, which lower the pH of the intestinal contents. This acidic environment promotes the retention of ammonia in the colon and enhances its excretion, thereby reducing blood ammonia levels in patients with hepatic encephalopathy. Additionally, the osmotic effect of lactulose draws water into the bowel, which increases stool volume and stimulates peristalsis, resulting in a laxative effect.

Pharmacological Properties

The pharmacological properties of DUPHALAC are primarily attributed to its active ingredient, lactulose. As an osmotic laxative, it increases the water content of the stool, leading to softer stools and more frequent bowel movements. Lactulose is also classified as a prebiotic, promoting the growth of beneficial gut bacteria, which can improve overall gut health. The onset of action typically occurs within 24 to 48 hours after administration, making it suitable for both short-term and long-term use in managing constipation.

Contraindications

DUPHALAC Syrup should not be used in patients with known hypersensitivity to lactulose or any of the other ingredients in the formulation. It is also contraindicated in individuals with galactosemia, a rare genetic disorder that affects the metabolism of galactose, as well as in patients with intestinal obstruction or perforation. Caution is advised when administering this syrup to patients with diabetes mellitus, as it may affect blood glucose levels due to the presence of sugars.

Side Effects

While DUPHALAC is generally well-tolerated, some patients may experience side effects. Common side effects include abdominal discomfort, bloating, flatulence, and diarrhea, particularly if the dosage is too high. In rare cases, more serious side effects such as electrolyte imbalances may occur, especially in patients with pre-existing conditions or those taking other medications that affect electrolyte levels. Patients should be advised to monitor their symptoms and consult a healthcare professional if they experience severe or persistent side effects.

Dosage and Administration

The dosage of DUPHALAC Syrup varies depending on the indication and the age of the patient. For adults and children over 14 years, the typical starting dose for constipation is 15 to 45 mL per day, which can be adjusted based on individual response. For children aged 7 to 14 years, the recommended dose is 15 to 30 mL per day, while for children aged 1 to 6 years, the dose is usually 5 to 15 mL per day. It is important to take the syrup with water or other liquids to enhance its efficacy. For patients with hepatic encephalopathy, the dosage may be higher, and it should be determined by a healthcare professional based on the severity of the condition.

Interactions

DUPHALAC Syrup may interact with certain medications, particularly those that can affect gastrointestinal motility or electrolyte balance. For example, the concurrent use of diuretics may increase the risk of electrolyte imbalances when taking lactulose. Additionally, medications that alter gut flora or affect the absorption of nutrients may also interact with lactulose. It is advisable for patients to inform their healthcare provider of all medications they are currently taking to avoid potential interactions.

Precautions

Patients should use DUPHALAC Syrup with caution if they have pre-existing gastrointestinal conditions, such as inflammatory bowel disease or a history of bowel obstruction. It is important to monitor the patient’s response to treatment and adjust the dosage as necessary. Pregnant and breastfeeding women should consult their healthcare provider before using this product to ensure it is safe for their specific situation. Regular follow-up appointments may be necessary to assess the effectiveness of the treatment and to make any necessary adjustments.

Clinical Studies

Numerous clinical studies have evaluated the efficacy and safety of lactulose in the treatment of constipation and hepatic encephalopathy. Research has demonstrated that lactulose effectively increases stool frequency and improves bowel consistency in patients with chronic constipation. Furthermore, studies have shown that lactulose is effective in reducing blood ammonia levels in patients with hepatic encephalopathy, leading to improved cognitive function and quality of life. These findings support the use of DUPHALAC Syrup as a reliable treatment option for both conditions.

Conclusion

DUPHALAC Syrup 150ML is a well-established treatment for constipation and hepatic encephalopathy, offering a gentle and effective solution for patients in need of bowel regulation. Its mechanism of action, pharmacological properties, and clinical efficacy make it a valuable addition to the therapeutic options available for managing these conditions. As with any medication, it is essential for patients to use DUPHALAC responsibly and under the guidance of a healthcare professional to ensure optimal outcomes.